U.S. markets open in 9 minutes

MyoKardia, Inc. (MYOK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
224.910.00 (0.00%)
At close: 4:00PM EST
Sign in to post a message.
  • S
    $DOC.V conversation

    VERY bullish on my DOC stock and the Telemedicine Sector in General. A few months back I got into a stock $MYOK (basically tracks your vitals from a device and stores it into your phone - pretty revolutionary actually and a great business model charging $9.99/month for the service). Was wondering if any of you are also tracking $LGVW. I'm in that one with 500 shares and 10,000 warrants and I really believe the Butterfly IQ+ is going to be what continues to revolutionize this industry and sector. Just throwing out some ideas.

    Currently my Telemedicine set up for 2021 by holding size is:

    1. DOC
    2. WELL
    3. LGVW
    4. MYOK (sold most for profits)
    5. TDOC
    6. AMWL

    Telemedicine makes up about 30% of my portfolio which matches the weight I have also put into EV.
  • F
    Any consensus on where to invest the windfall within the Biotech space?
  • N
    Can this stock even drop since it got bought at 225 a share?
  • S
    The whole purpose of high valuation is to make money by the C shell of the company. The CEo/board members and the advisors all make huge money! This is how it works-BMS will pay in cash/stock to the main investors of Myok! In turn, MYok will pay advisory fees to some non-descript advisory companies which are actaully owned by BMS board/ceos/advisors etc. The whole transaction is neatly crafted and packaged in such a way to hide fraud etc. Acquisition is one of the most fraudulent tool at disposal of the Ceos/Board to make insane amount of money! The wall street agents also make tons of money- remember thay are the one who protect these corrupt people by writing incorrect research on the target companies. The whole process is staged over a period of 9-18 months ! MYOK product is going to hit major problems; watch out for next 2 qtrs! The HCM product is an overhyped therapy.
  • c
    Question, do you sell now or wait for the 225 per share payout at close?
  • s
    Downgraded by BMO Capital Markets Outperform » Market Perform USD 225
    Initiates Coverage On Wells Fargo Equal-Weight USD 225
    Downgraded by Morgan Stanley Overweight » Equal Weight USD 121 » USD 225
    Reiterated by CSFB Outperform » Neutral USD 225
    Reiterated by Credit Suisse Outperform » Neutral USD 225 2020-10-06
    Downgrades Cowen Market Perform USD 145 » USD 225
    Downgraded by Wedbush Outperform » Neutral USD 127 » USD 225
    Downgraded by Citigroup Buy » Neutral USD 125 » USD 225
    Downgraded by JPMorgan Chase Overweight » Neutral
  • C
    I started following "lionstock-aletrs” (Gooogle it - off course without any space or dash in between the words) and their notifications are better than anyone else.
  • A
    Wha?... You're short?... AHAHAHAHAHAHAHAHAHA!!!
  • c
    short? oops.
  • M
    Cancer-drug powerhouse Bristol-Myers Squibb said it will buy biotech MyoKardia in a $13.1 billion all-cash deal aimed at expanding its lineup of heart drugs.
    Cancer-drug powerhouse Bristol-Myers Squibb said it will buy biotech MyoKardia in a $13.1 billion all-cash deal aimed at expanding its lineup of heart drugs.
  • R
    This is the move coming in Vir, their ceo a bright, bright fellow

    600% moves in vbiv adma solo uxin
  • P
  • K
    I just got a tip about MYOK from https://shr.link/Beststockalerts. What do you guys think?
  • P
    Pretty sure this deal will not be consummated at $225.00 per share. The BMY ceo even spoke to cnbc yesterday saying how myok drug is "revolutionary". 100k patients in the u.s. alone... say 50k patients x 45k cost per year = 2.25b annual rev. take out numbers for a company with rev is usually 10x rev so 13b is a steal given they can easily ramp up rev "fastly". i think the closing price on this deal will be 15-20% higher if a 3rd party does not come in and try to take them out at a higher price.
  • u
    uzma asma
    I was checking every single company share from penny to $300 not a single share given 5 to 10 doller extra. This share given $80 up. Very lucky who hold this share before. Just move out sold your share buy it again when it's fall again.
  • S
    Oh wow. A gem of a stock that has been sitting at the back of my portfolio with a little attention paid to since summer 0f 2017.

    As an unsavy, but lucky it appears, investor I mirror Faust's inquiry as what to do with the windfall.
  • Y
    Up 59% premarket. Love it!
  • m
    moon sun
    Now you know why biotechs are trading higher and higher, they are waiting to be bought out! Some will succeed in doing so, others not, it’s matter of luck.
  • u
    uzma asma
    Lucky guys who hold this share before sold it move out today u make good money buy it again when it's come down.
  • T
    The Trader
    Bristol Myers Squibb $BMY and MyoKardia $MYOK
    Invaluable buyout factsheet for traders and investors